Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
94.42
-1.87 (-1.94%)
Feb 13, 2026, 3:00 PM CST
43.50% (1Y)
| Market Cap | 24.99B +47.5% |
| Revenue (ttm) | 742.28M +52.0% |
| Net Income | -133.34M |
| EPS | -0.50 |
| Shares Out | 264.71M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,645,529 |
| Average Volume | 2,923,933 |
| Open | 96.07 |
| Previous Close | 96.29 |
| Day's Range | 94.19 - 97.77 |
| 52-Week Range | 63.40 - 134.17 |
| Beta | 0.25 |
| RSI | 54.02 |
| Earnings Date | Mar 28, 2026 |